In Brief: Nellcor Puritan Bennett/Aequitron
This article was originally published in The Gray Sheet
Nellcor Puritan Bennett/Aequitron: Waiting period in connection with the Hart-Scott-Rodino review of the companies' planned merger expires Oct. 26, clearing the way for completion of the deal. Finalization of the merger, announced in September ("The Gray Sheet" Sept. 16, I&W-1), is expected following the meeting of shareholders on Dec. 5...
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.